| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Inozyme Pharma, Inc. | Director | Stock Option (right to buy) | 28K | Jun 18, 2024 | Direct | ||
| Lexeo Therapeutics, Inc. | Director | Stock Option (right to buy) | 18K | Jun 25, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | Jun 25, 2024 | 1 | $0 | 4 | Jun 27, 2024 | Director |
| INZY | Inozyme Pharma, Inc. | Jun 18, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
| LXEO | Lexeo Therapeutics, Inc. | Feb 2, 2024 | 1 | $0 | 4 | Feb 6, 2024 | Director |
| LXEO | Lexeo Therapeutics, Inc. | Nov 2, 2023 | 0 | $0 | 3 | Nov 2, 2023 | Director |
| INZY | Inozyme Pharma, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
| INZY | Inozyme Pharma, Inc. | Jun 10, 2022 | 1 | $0 | 4 | Jun 14, 2022 | Director |
| INZY | Inozyme Pharma, Inc. | Jun 23, 2021 | 1 | $0 | 4 | Jun 24, 2021 | Director |